Lipoteichoic acid of Staphylococcus aureus enhances IL-6 expression in activated human basophils

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 35, Issue 4, 2012, Pages 363-374

  Jeon, Jun Ho ^a   Kim, Sun Kyung ^a   Baik, Jung Eun ^a   Kang, Seok Seong ^a   Yun, Cheol Heui ^a   Chung, Dae Kyun ^b,c   Han, Seung Hyun ^a  

^a Seoul National University   (South Korea)

^b Kyung Hee University   (South Korea)

^c RNA Inc   (South Korea)

Author keywords

Allergic inflammation; Basophils; IL 6; Lipoteichoic acid; Toll like receptor

Indexed keywords

CALCIMYCIN; CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOTEICHOIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR AP 1;

ALLERGIC INFLAMMATION; ARTICLE; BASOPHIL; CELL LEVEL; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; INTERLEUKIN 6 GENE; LEUKOCYTE ACTIVATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ANTIGENS, CD14; BASOPHILS; CALCIMYCIN; CALCIUM IONOPHORES; CELL LINE; DRUG SYNERGISM; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; NF-KAPPA B; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TETRADECANOYLPHORBOL ACETATE; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION FACTOR AP-1;

STAPHYLOCOCCUS AUREUS;

EID: 84862782434     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2012.03.001     Document Type: Article

References (52)

1. Min B. Basophils: what they 'can do' versus what they 'actually do'. Nat Immunol 2008, 9:1333-1339.
2. Sullivan B.M., Locksley R.M. Basophils: a nonredundant contributor to host immunity. Immunity 2009, 30:12-20.
3. Galli S.J., Tsai M., Piliponsky A.M. The development of allergic inflammation. Nature 2008, 454:445-454.
4. Micillo E., Bianco A., D'Auria D., Mazzarella G., Abbate G.F. Respiratory infections and asthma. Allergy 2000, 55(Suppl. 61):42-45.
5. Gern J.E., Busse W.W. Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol 2002, 2:132-138.
6. Sokol C.L., Chu N.Q., Yu S., Nish S.A., Laufer T.M., Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009, 10:713-720.
7. Komiya A., Nagase H., Okugawa S., Ota Y., Suzukawa M., Kawakami A., et al. Expression and function of toll-like receptors in human basophils. Int Arch Allergy Immunol 2006, 140(Suppl. 1):23-27.
8. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. Annu Rev Med 1987, 38:417-432.
9. Kaisho T., Takeuchi O., Kawai T., Hoshino K., Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 2001, 166:5688-5694.
10. Wicken A.J., Knox K.W. Lipoteichoic acids: a new class of bacterial antigen. Science 1975, 187:1161-1167.
11. West A.P., Koblansky A.A., Ghosh S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 2006, 22:409-437.
12. De Kimpe S.J., Kengatharan M., Thiemermann C., Vane J.R. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci U S A 1995, 92:10359-10363.
13. Joseph R., Shockman G.D. Synthesis and excretion of glycerol teichoic acid during growth of two streptococcal species. Infect Immun 1975, 12:333-338.
14. Wong G.G., Clark S.C. Multiple actions of interleukin 6 within a cytokine network. Immunol Today 1988, 9:137-139.
15. Vercelli D., Jabara H.H., Arai K., Yokota T., Geha R.S. Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis. Eur J Immunol 1989, 19:1419-1424.
16. Denzel A., Maus U.A., Rodriguez Gomez M., Moll C., Niedermeier M., Winter C., et al. Basophils enhance immunological memory responses. Nat Immunol 2008, 9:733-742.
17. Ishihara K., Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002, 13:357-368.
18. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990, 11:443-449.
19. Rola-Pleszczynski M., Stankova J. Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood 1992, 80:1004-1011.
20. Son Y.H., Jeong Y.T., Lee K.A., Choi K.H., Kim S.M., Rhim B.Y., et al. Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells. J Cardiovasc Pharmacol 2008, 51:71-77.
21. Junn E., Lee K.N., Ju H.R., Han S.H., Im J.Y., Kang H.S., et al. Requirement of hydrogen peroxide generation in TGF-beta 1 signal transduction in human lung fibroblast cells: involvement of hydrogen peroxide and Ca2+ in TGF-beta 1-induced IL-6 expression. J Immunol 2000, 165:2190-2197.
22. El Homsi M., Ducroc R., Claustre J., Jourdan G., Gertler A., Estienne M., et al. Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways. Am J Physiol Gastrointest Liver Physiol 2007, 293:G365-G373.
23. Bieneman A.P., Chichester K.L., Chen Y.H., Schroeder J.T. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion. J Allergy Clin Immunol 2005, 115:295-301.
24. Matsui K., Nishikawa A. Lipoteichoic acid from Staphylococcus aureus enhances allergen-specific immunoglobulin E production in mice. Clin Exp Allergy 2003, 33:842-848.
25. Matsui K., Nishikawa A. Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with an allergen. Clin Exp Allergy 2002, 32:783-788.
26. Ryu Y.H., Baik J.E., Yang J.S., Kang S.S., Im J., Yun C.H., et al. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int Immunopharmacol 2009, 9:127-133.
27. Jang K.S., Baik J.E., Han S.H., Chung D.K., Kim B.G. Multi-spectrometric analyses of lipoteichoic acids isolated from Lactobacillus plantarum. Biochem Biophys Res Commun 2011, 407:823-830.
28. Han S.H., Kim J.H., Martin M., Michalek S.M., Nahm M.H. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immun 2003, 71:5541-5548.
29. Han S.H., Jeon Y.J., Yea S.S., Yang K.H. Suppression of the interleukin-2 gene expression by aflatoxin B1 is mediated through the down-regulation of the NF-AT and AP-1 transcription factors. Toxicol Lett 1999, 108:1-10.
30. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003, 278:15587-15594.
31. Beetz A., Peter R.U., Oppel T., Kaffenberger W., Rupec R.A., Meyer M., et al. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. Int J Radiat Biol 2000, 76:1443-1453.
32. Kruger-Krasagakes S., Moller A., Kolde G., Lippert U., Weber M., Henz B.M. Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996, 106:75-79.
33. Yanagihara Y., Kajiwara K., Basaki Y., Ikizawa K., Akiyama K., Saito H. Induction of human IgE synthesis in B cells by a basophilic cell line, KU812. Clin Exp Immunol 1997, 108:295-301.
34. Shim S.Y., Ichikawa A., Yamashita M., Katakura Y., Teruya K., Mochizuki Y., et al. Construction of an in vitro allergy reaction evaluation system using human leukemia cell lines. Cytotechnology 2002, 40:75-83.
35. Hara T., Yamada K., Tachibana H. Basophilic differentiation of the human leukemia cell line KU812 upon treatment with interleukin-4. Biochem Biophys Res Commun 1998, 247:542-548.
36. Redrup A.C., Howard B.P., MacGlashan D.W., Kagey-Sobotka A., Lichtenstein L.M., Schroeder J.T. Differential regulation of IL-4 and IL-13 secretion by human basophils: their relationship to histamine release in mixed leukocyte cultures. J Immunol 1998, 160:1957-1964.
37. Higa S., Hirano T., Kotani M., Matsumoto M., Fujita A., Suemura M., et al. Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils. J Allergy Clin Immunol 2003, 111:1299-1306.
38. Matsuguchi T., Takagi K., Musikacharoen T., Yoshikai Y. Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood 2000, 95:1378-1385.
39. Lubick K., Jutila M.A. LTA recognition by bovine gammadelta T cells involves CD36. J Leukoc Biol 2006, 79:1268-1270.
40. Shan L., Redhu N.S., Saleh A., Halayko A.J., Chakir J., Gounni A.S. Thymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways. J Immunol 2010, 184:7134-7143.
41. Leonard M., Ryan M.P., Watson A.J., Schramek H., Healy E. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Kidney Int 1999, 56:1366-1377.
42. Craig R., Larkin A., Mingo A.M., Thuerauf D.J., Andrews C., McDonough P.M., et al. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release, Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 2000, 275:23814-23824.
43. Luo G., Hershko D.D., Robb B.W., Wray C.J., Hasselgren P.O. IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1249-R1254.
44. Kogut M.H., Genovese K.J., He H., Kaiser P. Flagellin and lipopolysaccharide up-regulation of IL-6 and CXCLi2 gene expression in chicken heterophils is mediated by ERK1/2-dependent activation of AP-1 and NF-kappaB signaling pathways. Innate Immun 2008, 14:213-222.
45. Lee Y.W., Lee W.H., Kim P.H. Oxidative mechanisms of IL-4-induced IL-6 expression in vascular endothelium. Cytokine 2010, 49:73-79.
46. Simeonova P.P., Toriumi W., Kommineni C., Erkan M., Munson A.E., Rom W.N., et al. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J Immunol 1997, 159:3921-3928.
47. Williams J.G., Bernstein S., Prager M. Effect of melatonin on activated macrophage TNF, IL-6, and reactive oxygen intermediates. Shock 1998, 9:406-411.
48. Rahman I., Biswas S.K., Jimenez L.A., Torres M., Forman H.J. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid Redox Signal 2005, 7:42-59.
49. Zhang J., Johnston G., Stebler B., Keller E.T. Hydrogen peroxide activates NFkappaB and the interleukin-6 promoter through NFkappaB-inducing kinase. Antioxid Redox Signal 2001, 3:493-504.
50. Kang S.S., Ryu Y.H., Baik J.E., Yun C.H., Lee K., Chung D.K., et al. Lipoteichoic acid from Lactobacillus plantarum induces nitric oxide production in the presence of interferon-gamma in murine macrophages. Mol Immunol 2011, 48:2170-2177.
51. Kang J.Y., Nan X., Jin M.S., Youn S.J., Ryu Y.H., Mah S., et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31:873-884.
52. Dykstra M., Cherukuri A., Sohn H.W., Tzeng S.J., Pierce S.K. Location is everything: lipid rafts and immune cell signaling. Annu Rev Immunol 2003, 21:457-481.